Pages that link to "Q24245569"
Jump to navigation
Jump to search
The following pages link to Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks (Q24245569):
Displaying 26 items.
- Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack (Q24241777) (← links)
- 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society (Q27341873) (← links)
- Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation (Q28210958) (← links)
- Stroke prevention in atrial fibrillation--things can only get better (Q28213581) (← links)
- Improving stroke prevention therapy for patients with atrial fibrillation in primary care: protocol for a pragmatic, cluster-randomized trial. (Q30830699) (← links)
- Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants (Q33936087) (← links)
- Prevention of cardioembolic stroke (Q35648111) (← links)
- Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial (Q36030528) (← links)
- Antiplatelet versus anticoagulation treatment for patients with heart failure in sinus rhythm. (Q36133383) (← links)
- Novel anticoagulants in atrial fibrillation stroke prevention (Q36443814) (← links)
- A systematic review of Cochrane anticoagulation reviews. (Q37417509) (← links)
- Stroke prevention in atrial fibrillation: putting the guidelines into practice (Q37801914) (← links)
- Prevention and management of TURP-related hemorrhage (Q37918319) (← links)
- The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure (Q38064758) (← links)
- Antiplatelet therapy in prevention of cardio- and venous thromboembolic events (Q38162123) (← links)
- Antiplatelet Therapy During PCI for Patients with Stable Angina and Atrial Fibrillation (Q38535999) (← links)
- Antithrombotic treatment in atrial fibrillation (Q41878910) (← links)
- Effectiveness and patient safety of platelet aggregation inhibitors in the prevention of cardiovascular disease and ischemic stroke in older adults - a systematic review (Q42676674) (← links)
- Stroke: secondary prevention (Q46722175) (← links)
- Trend of Prevalence of Atrial Fibrillation and use of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation in South Korea (2002-2013). (Q48356499) (← links)
- The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial (Q51411516) (← links)
- Antiplatelet therapy for preventing stroke in people with atrial fibrillation (Q58040934) (← links)
- Anticoagulation for stroke prevention: high effectiveness, more cost benefit? (Q79141729) (← links)
- The role of aspirin for stroke prevention in atrial fibrillation (Q84593066) (← links)
- Anticoagulation for atrial fibrillation after intracranial hemorrhage: A systematic review (Q88000130) (← links)
- Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial (Q92293152) (← links)